Figures & data
Figure 3 Particle size distribution of iron oxide nanoparticles and chitosan-coated iron oxide nanoparticles by dynamic light scattering.
![Figure 3 Particle size distribution of iron oxide nanoparticles and chitosan-coated iron oxide nanoparticles by dynamic light scattering.](/cms/asset/eaa414fd-c6e0-47e0-9daa-8d6c8ac46ee6/dijn_a_34348_f0003_b.jpg)
Figure 4 Zeta potential of nanoparticles by a Malvern Zetasizer Nano instrument. (A) Uncoated iron oxide nanoparticles and (B) chitosan-coated iron oxide nanoparticles.
![Figure 4 Zeta potential of nanoparticles by a Malvern Zetasizer Nano instrument. (A) Uncoated iron oxide nanoparticles and (B) chitosan-coated iron oxide nanoparticles.](/cms/asset/f7c9d65b-629b-407b-ae0e-4c6fd21c9b36/dijn_a_34348_f0004_b.jpg)
Figure 5 X-ray diffraction results for synthesized nanoparticles. (A) Iron oxide nanoparticles and (B) chitosan-coated iron oxide nanoparticles.
![Figure 5 X-ray diffraction results for synthesized nanoparticles. (A) Iron oxide nanoparticles and (B) chitosan-coated iron oxide nanoparticles.](/cms/asset/864e7bcc-5d04-49e1-8848-95b54a699a95/dijn_a_34348_f0005_c.jpg)
Figure 6 Magnetization curves of chitosan-coated iron oxide nanoparticles as measured by vibrating sample magnetometry at room temperature. (A) Iron oxide nanoparticles and (B) chitosan-coated iron oxide nanoparticles.
![Figure 6 Magnetization curves of chitosan-coated iron oxide nanoparticles as measured by vibrating sample magnetometry at room temperature. (A) Iron oxide nanoparticles and (B) chitosan-coated iron oxide nanoparticles.](/cms/asset/456367cc-58f3-4d5c-84f0-81d133bc1231/dijn_a_34348_f0006_c.jpg)
Figure 8 Transmission electron micrographs of chitosan-coated Fe3O4 nanoparticles attached to cell surfaces.
![Figure 8 Transmission electron micrographs of chitosan-coated Fe3O4 nanoparticles attached to cell surfaces.](/cms/asset/9c6eccfd-6b39-42c4-96b2-f7054036822a/dijn_a_34348_f0008_b.jpg)
Figure 9 Prussian blue staining of iron in osteoblasts. Osteoblast SV40 incubated with chitosan-coated iron oxide nanoparticles (A) and uncoated iron oxide nanoparticles (B) at a concentration of 200 μg/mL for 24 hours.
Note: Scale bar 50 μm.
![Figure 9 Prussian blue staining of iron in osteoblasts. Osteoblast SV40 incubated with chitosan-coated iron oxide nanoparticles (A) and uncoated iron oxide nanoparticles (B) at a concentration of 200 μg/mL for 24 hours.Note: Scale bar 50 μm.](/cms/asset/0bb89f89-0744-49fb-bfc8-f13b4767df57/dijn_a_34348_f0009_c.jpg)
Figure 10 Osteoblast density in the presence of magnetic nanoparticles after one, 3, and 6 days of culture.
Notes: Nanoparticle concentration was 100 μg/mL. Data are shown as the mean ± standard error of the mean (n =4). *P < 0.05 compared with control samples.
![Figure 10 Osteoblast density in the presence of magnetic nanoparticles after one, 3, and 6 days of culture.Notes: Nanoparticle concentration was 100 μg/mL. Data are shown as the mean ± standard error of the mean (n =4). *P < 0.05 compared with control samples.](/cms/asset/93ce0313-db9a-454d-af50-5fafbe9f8668/dijn_a_34348_f0010_b.jpg)
Figure 11 Cell viability of SV40 osteoblasts incubated with different concentrations of nanoparticles after 3 days.
Notes: Data are shown as the mean ± standard error of the mean (n = 4). *P < 0.05 compared with the Fe3O4 group.
![Figure 11 Cell viability of SV40 osteoblasts incubated with different concentrations of nanoparticles after 3 days.Notes: Data are shown as the mean ± standard error of the mean (n = 4). *P < 0.05 compared with the Fe3O4 group.](/cms/asset/d6e75079-0b96-4f7b-8868-e1284326244f/dijn_a_34348_f0011_b.jpg)
Figure 12 Lactate dehydrogenase assay of osteoblasts incubated with chitosan-coated iron oxide nanoparticles and iron oxide nanoparticles (200 μg/mL) for 3 days and 6 days.
Notes: Data are shown as the mean ± standard error of the mean (n = 4). *P < 0.05 compared with control samples.
![Figure 12 Lactate dehydrogenase assay of osteoblasts incubated with chitosan-coated iron oxide nanoparticles and iron oxide nanoparticles (200 μg/mL) for 3 days and 6 days.Notes: Data are shown as the mean ± standard error of the mean (n = 4). *P < 0.05 compared with control samples.](/cms/asset/98bab37a-922a-4c96-be10-26d778b3f8ea/dijn_a_34348_f0012_b.jpg)
Figure 13 Intracellular total protein synthesis of osteoblasts incubated with chitosan-coated iron oxide nanoparticles and iron oxide nanoparticles (200 μg/mL) for 7, 14, and 21 days.
Notes: Data are shown as the mean ± standard error of the mean (n = 4). *P < 0.05 compared with control samples. Osteoblast seeding density was 100,000 cells/cm2.
![Figure 13 Intracellular total protein synthesis of osteoblasts incubated with chitosan-coated iron oxide nanoparticles and iron oxide nanoparticles (200 μg/mL) for 7, 14, and 21 days.Notes: Data are shown as the mean ± standard error of the mean (n = 4). *P < 0.05 compared with control samples. Osteoblast seeding density was 100,000 cells/cm2.](/cms/asset/52c5dbcf-bbf3-47ed-a39e-3677a3ac3421/dijn_a_34348_f0013_b.jpg)
Figure 14 Alkaline phosphatase activity of osteoblasts after 7, 14, and 21 days of culture.
Notes: Data are shown as the mean ± standard error of the mean (n = 4). *P < 0.05 compared with control samples at the same time point; **P < 0.05 compared with the chitosan-coated nanoparticles at the same time point.
![Figure 14 Alkaline phosphatase activity of osteoblasts after 7, 14, and 21 days of culture.Notes: Data are shown as the mean ± standard error of the mean (n = 4). *P < 0.05 compared with control samples at the same time point; **P < 0.05 compared with the chitosan-coated nanoparticles at the same time point.](/cms/asset/43ccef35-9091-46e9-9ceb-690f5cc63430/dijn_a_34348_f0014_b.jpg)